Less regulation of weight-loss drug would make Wegovy accessible to more people
Ministers are launching a £40m pilot scheme to trial wider access to the controversial slimming jab Wegovy, to examine how people could receive the drug outside hospitals.
Under current advice from the National Institute for Health and Care Excellence drugs regulator, Wegovy is only given via specialist weight management services, usually based in hospitals.
